找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Beyond Becquerel and Biology to Precision Radiomolecular Oncology: Festschrift in Honor of Richard P; Vikas Prasad Book‘‘‘‘‘‘‘‘ 2024 The E

[复制链接]
楼主: TUMOR
发表于 2025-3-30 11:41:46 | 显示全部楼层
发表于 2025-3-30 15:48:31 | 显示全部楼层
发表于 2025-3-30 20:13:41 | 显示全部楼层
https://doi.org/10.1007/978-94-009-0793-5poor prognosis with a median overall survival time of only 9–15 months. The infiltrating nature of the tumour cells, inter- and intra-tumoral molecular heterogeneity and the tumour’s propensity to hide behind the blood-brain barrier are the key causes of the insufficiency of the optimal available tr
发表于 2025-3-30 21:51:29 | 显示全部楼层
发表于 2025-3-31 01:35:06 | 显示全部楼层
International Corporate Brand Managementand survival. Targeted cancer therapeutics are amongst the major treatment options for cancer today. These treatments are more selective for cancer cells and improve the quality of life for cancer patients undergoing therapy. Nevertheless, cardiotoxicity is a frequent side effect in targeted therapi
发表于 2025-3-31 05:36:43 | 显示全部楼层
发表于 2025-3-31 09:41:23 | 显示全部楼层
https://doi.org/10.1007/978-3-658-00406-4heir scientific basis, further aspects are important for new medical procedures to be introduced into broad clinical care. In this matter, we in Germany have special experiences with PET which is still not fully recognized by statutory health insurances as the standard procedure of choice for many i
发表于 2025-3-31 14:44:36 | 显示全部楼层
International Courts and Mass Atrocity(theranostics) of prostate cancer, particularly in the metastatic castrate-resistant state. Numerous investigations from around the world in both academic and pharma settings are focused on research and development of safe and effective PSMA-based theranostic agents. Encouraging results from retrosp
发表于 2025-3-31 19:42:35 | 显示全部楼层
Understandings of Law in Croatia, 1980s and ended up with radiomolecular precision oncology in 2020s. The author also had own interests which Richard Baum did not touch. The author worked some time with oligonucleotide radionuclide therapy (radionanotargeting) in the 1990s learning that it will be impossible in clinical practice. O
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-9 17:17
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表